APA (7th ed.) Citation

Du, J., Han, S., Zhou, H., Wang, J., Wang, F., Zhao, M., . . . Liu, Z. (2024). Targeted protein degradation combined with PET imaging reveals the role of host PD-L1 in determining anti-PD-1 therapy efficacy. European journal of nuclear medicine and molecular imaging, 51(12), 3559-3571. https://doi.org/10.1007/s00259-024-06804-9

Chicago Style (17th ed.) Citation

Du, Jinhong, et al. "Targeted Protein Degradation Combined with PET Imaging Reveals the Role of Host PD-L1 in Determining Anti-PD-1 Therapy Efficacy." European Journal of Nuclear Medicine and Molecular Imaging 51, no. 12 (2024): 3559-3571. https://doi.org/10.1007/s00259-024-06804-9.

MLA (9th ed.) Citation

Du, Jinhong, et al. "Targeted Protein Degradation Combined with PET Imaging Reveals the Role of Host PD-L1 in Determining Anti-PD-1 Therapy Efficacy." European Journal of Nuclear Medicine and Molecular Imaging, vol. 51, no. 12, 2024, pp. 3559-3571, https://doi.org/10.1007/s00259-024-06804-9.